NFKB1 and colorectal cancer: Moreover, PS-341 and NPI0052 can enhance chemosensitivity and the tumoricidal response to CPT-11 in colorectal cancer by blocking chemotherapy-induced NF-κB activation and expression of genes involved in cancer cell survival (15–18).